Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study

Baseline GLR is a practical, cost-effective biomarker that independently predicts OS in advanced NSCLC patients treated with nivolumab. Elevated GLR likely reflects metabolic dysfunction and impaired immune reserve, both unfavorable for PD-1 blockade efficacy. Prospective studies are warranted to validate GLR and define its role in clinical decision-making.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-02-12
DOI
https://doi.org/10.3389/fimmu.2026.1714533
Citations
1
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
24.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study

Teoman Şakalar, Sedat Yıldırım, Ertuğrul Bayram, muslih urun et al.
1 citations
Frontiers in Immunology
Inflammatory Biomarkers in Disease Prognosis
24.20
article

Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study

Teoman Şakalar, Sedat Yıldırım, Ertuğrul Bayram, muslih urun, Pervin Can Şancı, Hayati Arvas, Gözde Ağdaş, Sedat Biter, Muhammet Cengiz, Duygu Bayir, Mehmet Haluk Yücel, Erdem Kolemen, Ayse Nuransoy Cengiz, Devrim Cabuk, Havva Yesil Cinkir, Umut Kefeli, Canan Yıldız, Mustafa Ersoy, Berrak Mermeit, Ezgi Turkoglu, Anil Karakayalı, Erkam Kocaaslan, Elif Sahin, Mehmet Mutlu, Emel Mutlu
article en
1 citations

Abstract

Baseline GLR is a practical, cost-effective biomarker that independently predicts OS in advanced NSCLC patients treated with nivolumab. Elevated GLR likely reflects metabolic dysfunction and impaired immune reserve, both unfavorable for PD-1 blockade efficacy. Prospective studies are warranted to validate GLR and define its role in clinical decision-making.

Frontiers in ImmunologyVol. 17
Van Yüzüncü Yıl Üniversitesi (TR), Dicle University (TR), Yozgat Bozok Üniversitesi (TR), University Medical Center (US), Istanbul Medipol University (TR), Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Hastanesi (TR), İstanbul Eğitim ve Araştırma Hastanesi (TR), Hitit Üniversitesi Çorum Eğitim ve Araştırma Hastanesi (TR), Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR), Ministry of Food Agriculture and Livestock (TR), Kahramanmaraş Sütçü İmam University (TR), Kocaeli Üniversitesi (TR), Afyon Kocatepe University (TR), Cukurova University (TR), Gaziantep University (TR), Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 1%
Inflammatory Biomarkers in Disease Prognosis
24.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.